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Background. In the context of global malaria elimination efforts, special attention is being paid to submicroscopic Plasmodium 
falciparum infections. In pregnant, sub-Saharan African women, such infections are more prevalent than microscopic infections, 
and are thought to have adverse effects on both mothers’ and newborns’ health. However, no study has studied the dynamics and de-
terminants of these infections throughout pregnancy. Retard de Croissance Intra-uterin et Paludisme (RECIPAL), a preconception 
cohort study carried out in Benin between 2014 and 2017, represented a unique opportunity to assess this issue.
Methods. We used data from 273 pregnant Beninese women who were followed-up from preconception to delivery. We studied 
the dynamics of and factors influencing submicroscopic (and microscopic) P. falciparum infections during the 3 trimesters of preg-
nancy, using an ordinal logistic mixed model.
Results. The incidence rate of submicroscopic P. falciparum infections during pregnancy was 12.7 per 100 person-months (95% confi-
dence interval [CI] 10.8–14.9), compared to 6.7 per 100 person-months (95% CI 5.5–8.1) for microscopic infections. The prevalences were 
highest in the first trimester for both submicroscopic and microscopic infections. After adjustment for potential confounding factors, we 
found that those of young age and those with a submicroscopic P. falciparum infection prior to pregnancy were at significantly higher risks 
of submicroscopic and microscopic infections throughout pregnancy, with a more pronounced effect in the first trimester of pregnancy.
Conclusions. The first trimester of pregnancy is a particularly high-risk period for P. falciparum infection during pregnancy, 
especially for the youngest women. Malaria prevention tools covering the preconception period and early pregnancy are urgently 
needed to better protect pregnant women and their newborns.
Keywords. dynamic; submicroscopic P. falciparum infections; pregnancy; preconception cohort; sub-Saharan Africa.
Approximately 30 million pregnant women are exposed to ma-
laria every year [1, 2] in sub-Saharan Africa. Many studies have 
highlighted the impact of malaria in pregnancy (MiP), with ad-
verse consequences such as maternal anemia, prematurity, and 
low birth weight [3–6] associated with a high risk of maternal and 
infant mortality [7]. To protect women against MiP, the World 
Health Organization recommends different strategies, such as 
intermittent preventive treatment in pregnancy (IPTp) with 
sulfadoxine-pyrimethamine and insecticide-treated nets, which 
have led to substantial improvements in birth outcomes [8–10] 
and reductions of malaria-related mortality and morbidity rates 
[11]. However, these policies remain suboptimal, in particular 
because the first trimester of pregnancy currently remains un-
protected for different reasons. Firstly, IPTp with sulfadoxine-
pyrimethamine is contraindicated in the first trimester due to 
possible teratogenic effects [12]. Secondly, in sub-Saharan Africa, 
pregnant women habitually attend their first antenatal consul-
tation only in the second trimester [13, 14]. Therefore, little is 
known about the actual infection risk during the first trimester, 
which is likely an under-protected period [15, 16]. This is critical, 
since malaria in early pregnancy has been shown to be associated 
with deleterious pregnancy outcomes [17–19].
Moreover, in the last decade, several studies have revealed a 
high prevalence of carriage of submicroscopic infections, detected 
by polymerase chain reaction (PCR)-based molecular methods 
that are more sensitive than the standard malaria detection tools, 
and shedding new light on the real prevalence of malaria infec-
tions [20], especially in pregnant women [21]. In addition, such 
submicroscopic infections—especially those occurring early in 
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pregnancy [21] are suspected to adversely affect womens’ and 
newborns’ health [21–23], but are nevertheless usually asympto-
matic and, thus, remain untreated during pregnancy.
The Retard de Croissance Intra-uterin et Paludisme 
(RECIPAL) study, a cohort study of malaria in pregnant women 
followed-up from preconception to delivery in Benin, was a 
unique opportunity to assess the dynamics and determinants of 
submicroscopic (and microscopic) infections throughout preg-
nancy, particularly in the first trimester.
METHODS
Study Design
RECIPAL is a preconception cohort study that assessed the ef-
fects of malaria infection (microscopic and submicroscopic) 
during pregnancy on the mother and the fetus. The study design 
has been described elsewhere [15]. Briefly, it was conducted in 
southern Benin from June 2014 to August 2017. A total of 1214 
women of reproductive age (WRA) were recruited (primary co-
hort). The subsample of women who became pregnant was then 
followed-up monthly in the study’s health facilities throughout 
pregnancy, until delivery (secondary cohort). During the study, 
infections with Plasmodium falciparum were detected by both 
thick blood smears (TBSs) and PCRs. Only infected women (de-
tected by TBS and rapid diagnostic test [RDT], when applicable) 
were treated. PCRs were performed later. The project provided 
all treatments given for any infection occurring during preg-
nancy [24].
Preconception Follow-up: Primary Cohort
The study was introduced to the local authorities and various ap-
proaches were used to recruit WRA, including repeated aware-
ness sessions, participation of the community’s leaders, and 
door-to-door recruitment. Another study (Clinical development 
of a VAR2CSA-based Placental Malaria Vaccine [PlacMalVac]), 
which concerned the development of a Variant surface antigen 
2 chondroitin sulfate A-based vaccine against placental malaria, 
was implemented in the same area and included exclusively 
primigravidae [25]. The women enrolled in the vaccine-related 
study were no longer eligible for RECIPAL.
At enrollment, demographics, socioeconomic characteristics, 
and reproductive histories were collected and all women were 
screened for malaria. Women were visited at home monthly to 
record the first day of the last menstrual period and a urinary 
pregnancy test was performed on all women who did not have a 
until pregnancy was confirmed with a maximum of 24 months.
Gestational Follow-up: Secondary Cohort
Once the pregnancy was confirmed, the women were followed-up 
monthly until delivery. Clinical, obstetrical, and anthropometric 
data, as well as malaria infection screening data, were collected. 
A  gestational age (GA) estimation was based either on the last 
menstrual period or first ultrasound scan [26]. A TBS and an RDT 
were performed in the case of a fever or malaria-like symptoms. 
According to recommendations in Benin (at least 2 doses during 
pregnancy), IPTp was given from the second trimester.
Laboratory Procedures
P.  falciparum was (1) quantified by the Lambaréné technique, 
with a detection threshold estimated at 5 parasites/µL [24, 27]; 
and (2) tested by real-time quantitative PCR that targeted the 
18S ribosomal ribonucleic acid gene [28, 29]. A negative control 
with no DNA template was run in all reactions. The RDT used 
was the Pf + pan rapid test (SD Bioline Ag, IDA Foundation; 
BioSynex) [15].
Ethics Statement
The Ethics Committee of the Institut des Sciences Biomédicales 
Appliquées approved this study, as did the Ministry of Health in 
Benin. Before any enrollment, the study was explained in the local 
language to the woman, and her freely given consent was obtained.
Statistical Analysis
Our main objective was to study the dynamics and the deter-
minants of submicroscopic (as well as microscopic) P.  falcip-
arum infections during pregnancy, with a particular focus on 
the first trimester.
Our analysis sample was the 273 women followed-up from pre-
conception until delivery, allowing for the definition of their P. fal-
ciparum infection status during the 3 trimesters of pregnancy.
Our dependent variable was a time-dependent, ordinal vari-
able with 3 classes (negative, submicroscopic, and microscopic 
infection status), summarizing the P. falciparum infection status 
of the woman in each trimester. This variable was built in 2 
steps. First, at each visit, the P. falciparum infection was defined 
as negative if all tests (TBS, PCR, and RDT, when applicable) 
were negative; as a submicroscopic infection if the TBS (and 
RDT, when applicable) was negative but the PCR was positive; 
and as a microscopic infection if the TBS or RDT (when appli-
cable) was positive whatever the PCR was positive or negative.
Second, in each trimester, the P. falciparum infection status 
was defined as the sum of P.  falciparum infections during the 
visits of the trimester. Thus, for a given trimester, the P. falcip-
arum infection status of a women was either:
 1. Negative (no P. falciparum infection), if the woman was diag-
nosed as negative at all visits during the trimester;
 2. A submicroscopic P. falciparum infection, if the woman was 
diagnosed as having a submicroscopic infection during at 
least 1 visit and was not diagnosed as having a microscopic 
infection at any visit during the trimester; or
 3. A microscopic P.  falciparum infection, if the woman was 
diagnosed as having a microscopic infection during at least 
1 visit during the trimester.
An example is shown (Figure 1) of a hypothetical pregnant 
women who would have attended 8 visits during the 3 trimesters.
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As explanatory variables, we considered sociodemographic 
characteristics, including maternal age (2 classes, according to 
the median of our sample: 26 years old), marital status, residence 
area, ethnicity, and education level. We also considered clinical 
characteristics, including the presence of a P. falciparum infec-
tion before pregnancy (ie, at inclusion in the primary cohort; 
negative, submicroscopic, microscopic); gravidity; number of 
IPTp doses during pregnancy until the current trimester (time-
dependent variable varying according to the trimester); trimes-
ters of pregnancy (≤14 weeks of gestation [wg], 15–27 wg, and 
≥28 wg for the first, second, and third trimesters, respectively); 
P. falciparum infection status from the previous trimester (set to 
negative for the first trimester); and season at delivery.
Statistical Model
Since our dependent variable was a repeated (at the 3 trimesters) 
ordinal variable, we performed a classic, ordinal, logistic, mixed 
model to assess the determinants of P.  falciparum infection 
status’ dynamics according to the trimesters of pregnancy. The 
hypothesis of the parallel lines was tested and was not violated 
for any covariate. The variables for which the P values were 
less than 0.20 in a univariate analysis were introduced in the 
multivariate model.
A preliminary analysis showed a possible interaction be-
tween having a P.  falciparum infection before pregnancy and 
maternal age, which depended on the trimester of pregnancy. 
For this reason, we introduced in our model a second-order 
interaction term between P. falciparum infections before preg-
nancy, maternal age, and trimester.
We performed a step-by-step backward selection to eliminate 
the nonsignificant, independent variables introduced in the in-
itial multivariate model. The variables for which the P values 
were less than 0.05 were retained in the final multivariate model.
In an ordinal logistic mixed model, the estimated odds ratios 
are cumulative, and then do not allow for a comparison of 
the risk of a submicroscopic (or microscopic) infection status 
Figure 1. Construction of the Plasmodium falciparum infection status per trimester variable, in a hypothetical pregnant woman who would have attended 2 visits in the first 
trimester, 3 visits in the second trimester, and 3 visits in the third trimester. If at the 2 visits in the first trimester the woman was diagnosed as negative, in the second trimester 
she was diagnosed as negative/submicroscopic/negative, and at least at 1 of the 3 visits in the third trimester she was diagnosed as microscopic, she was therefore classified, 
respectively, as having a negative infection status, submicroscopic infection status, and microscopic infection status for the first, second and third trimesters. Abbreviations: 
Micro, microscopic P. falciparum infection at the visit; Neg, no P. falciparum infection (negative) at the visit; Sub, submicroscopic P. falciparum infection at the visit. 
Figure 2. Flow chart of Retard de Croissance Intra-uterin et Paludisme (RECIPAL) study, June 2014–August 2017, Benin. Abbreviation: WRA, women of reproductive age.
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versus a negative status according to the covariates. Therefore, 
we derived from the model the predicted probabilities (risk) of 
a P. falciparum infection status according to the submicroscopic 
infection status before pregnancy and maternal age.
Stata version 13 for Windows (Stata Corp., College Station, 
TX) was used for all statistical analyses.
RESULTS
During follow-up (Figure 2), 1214 WRA were included. Among 
them, 411 women (33.8%) became pregnant and 273 (66.4%) 
delivered with a complete follow-up. We compared the 138 
lost to follow-up and the 273 pregnant women included in 
our analysis according to maternal age, gestational rank, and 
P.  falciparum infection status before pregnancy, and found no 
significant difference (Supplementary Table 1). Out of the 138 
pregnant women lost to follow-up, the main causes were mis-
carriages (52.17%) and withdrawals of consent (33.33%).
Pregnant Womens’ Characteristics and Malaria Infection During the 
Follow-up
Table 1 presents the general characteristics of the pregnant 
women. More than three-quarters of the women were under 
30 years of age, and 8.8% of them were primigravidae. The first 
antenatal consultation occurred, on average, at 7.1 wg and the 
mean GA at delivery was 39.2 wg. The majority of pregnant 
women (74.3%) belonged to the Toffin ethnic group. Almost 
1 in 4 women (24.9%) were carrying submicroscopic P. falcip-
arum infections before pregnancy. All but 10 women received at 
least 1 dose of IPTp during the follow-up. Out of the 263 preg-
nant women who received IPTp, the average GA at the first in-
take of IPTp was at 23 wg ± 5 wg.
Figure 3 shows the evolution of submicroscopic and micro-
scopic P. falciparum infections from preconception to delivery 
in the study. At each visit, the proportion of submicroscopic 
P. falciparum infections was higher than the proportion of mi-
croscopic P.  falciparum infections. Both submicroscopic and 
microscopic P. falciparum infections were at their highest level 
during the first trimester. The overall incidence rates of submi-
croscopic and microscopic P. falciparum infections during preg-
nancy were 12.7 (95% confidence interval [CI] 10.8–14.9) and 
6.7 (95% CI 5.5–8.1) per 100 persons-months, respectively.
Figure 4 shows the proportions of women with microscopic 
and submicroscopic infections at each trimester. The propor-
tion with submicroscopic infections was always higher than the 
proportion with microscopic infections (29.2% vs 20.2% for the 
first trimester, respectively; 29.1% vs 17.3% for the second tri-
mester, respectively; and 20.5% vs 17.2% for the third trimester, 
respectively).
Factors Contributing to the Plasmodium falciparum Infection Dynamics
 In the final multivariate model, the statistically signifi-
cant factors contributing to P.  falciparum infection status 
(submicroscopic and microscopic) dynamics were ethnicity 
(P = .04), cumulative number of IPTp doses (P = .01), and sub-
microscopic P. falciparum infection status for the previous tri-
mester (P  <  .001). In addition, the second-order interaction 
term between maternal age, P. falciparum infection status before 
pregnancy, and trimester was also significant (P < .001).
The predicted probabilities of having a P. falciparum infection 
according to maternal age and having a P. falciparum infection 
before pregnancy were performed (only the results regarding 
the submicroscopic infection class are shown, in Figures 5 and 
Table 1. General Characteristics of the Pregnant Women Followed-up 
Until Delivery in the Retard de Croissance Intra-uterin et Paludisme 
(RECIPAL) Study, N = 273, Benin, 2014–2017
Characteristics Total
Mean ± SD or  
proportion (95% CI)
Age, years 273 26.8 ± 4.9
 <23 55 20.1 (15.8–25.4)
 23–30 165 60.4 (54.5–66.1)
 >30 53 19.4 (15.1–24.6)
Gestational age at the  
first ANC, wg
273 7.1 ± 2.5
ITN possession 267 97.8 (95.2–99.0)
Gravidity 273 …
 Primigravida 24 8.8 (5.9–12.8)
 Secondigravida 40 14.6 (10.9–19.4)
 Multigravida 209 76.6 (71.1–81.2)
Ethnic group, n 273  
 Toffin 203 74.35 (68.6–77.2)
 Fon 21 7.7 (5.0–11.5)
 Aîzo 39 14.28 (12.0–16.5)
 Others 10 3.7 (1.5–5.8)
Education level, n 273  
 Illiterate 195 71.4 (65.7–76.5)
 Literate 78 28.6 (23.5–34.2)
Professional status, n 273  
 Active 261 95.6 (92.4–97.5)
 Not active 8 2.9 (1.5–5.8)
 In training 4 1.5 (.5–3.9)
Marital status, n 273  
 Cohabitation 18 6.6 (4.2–10.2)
 Married 255 93.4 (89.7–95.8)
P. falciparum infection before  
pregnancy, n
273  
 Negative 188 68.9 (63.1–74.1)
 Submicroscopic 68 24.9 (20.1–30.4)
 Microscopic 17 6.2 (3.9–9.8)
Gestational age at delivery, wg 273 39.2 ± 2.2
Number of ANC visits (scheduled  
and unscheduleded)  
during pregnancy
273 8.3 ±  1.3
Number of IPTp doses 273  
 0 10 3.7 (2.0–6.7)
 1 54 19.8 (15.4–25.0)
 2 171 62.6 (56.7–68.2)
 3 38 13.9 (10.3-18.6)
Abbreviations: ANC, antenatal consultation; CI, confidence interval; IPTp, intermittent pre-
ventive treatment in pregnancy; ITN, insecticide-treated nets; P. falciparum, Plasmodium 
falciparum; SD, standard deviation; wg, weeks of gestation.
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6). Figures 5 and 6 show, respectively, the predicted probabil-
ities of having submicroscopic and microscopic infections for 
each trimester. Younger women with a submicroscopic P. falcip-
arum infection before conception had the highest probability 
of harboring a submicroscopic or microscopic P.  falciparum 
infection throughout pregnancy. More specifically, this interac-
tion between age and infection status before pregnancy was sig-
nificant at each trimester. The highest risk was found in young 
women with a submicroscopic infection before pregnancy at 
each trimester, and this risk was higher in the first and second 
trimesters, compared to the third trimester.
DISCUSSION
To our knowledge, RECIPAL is the first longitudinal study 
of malaria in sub-Saharan Africa to follow women from pre-
conception right through to delivery. This was an excellent 
opportunity to study the dynamics of submicroscopic (as well 
as microscopic) P.  falciparum infections and their determin-
ants throughout pregnancy, starting from the first trimester. We 
observed that the proportions of women with submicroscopic 
P. falciparum infections were consistently higher than those of 
women with microscopic P. falciparum infections during preg-
nancy, with a cumulative incidence rate for submicroscopic in-
fections that was twice that of microscopic infections. This is 
consistent with several other studies in pregnant women [21, 
30–32]. In addition to this confirmation of previous findings, 
the study revealed that the proportion of infected women was 
highest in the first trimester.
We also found that being a young age and having a submi-
croscopic infection prior to pregnancy were associated with 
increased risks of both submicroscopic and microscopic infec-
tions in the different trimesters of pregnancy. The first result 
Figure 3. Dynamics of Plasmodium falciparum infections before and during pregnancy, Retard de Croissance Intra-uterin et Paludisme (RECIPAL) 2014–2017, Benin.
Figure 4. Proportion of women with submicroscopic and microscopic infection status in each trimester of pregnancy, Retard de Croissance Intra-uterin et Paludisme 
(RECIPAL) 2014–2017, Benin. P values are from Chi-square tests. 
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is well known. Indeed, possible explanations could be that (1) 
younger women, in which primi- and secondigravidae are 
overrepresented [25], have low or no immunity to the relevant 
parasite antigens, compared to the older group [12, 33–35]; and 
(2) women exhibited different behavior, with respect to malaria 
prevention tools during pregnancy (the use of bed nets, for ex-
ample), in relation to age. To our knowledge, the relationship be-
tween having a submicroscopic infection before pregnancy and 
the risk of infection during pregnancy has never been shown. 
This extends preliminary results of the RECIPAL study on mi-
croscopic infections [36] that showed that women infected be-
fore pregnancy were more at risk of having an infection in the 
first trimester. This finding is important in public health terms, 
since it suggests that the preconception period should be con-
sidered as a vulnerable period, just as much as pregnancy itself. 
A recent study that was conducted on another subset of primi-
gravidae [25]in the same area showed that infections occurring 
during the first trimester were predominantly (70%) composed 
of persistent P.  falciparum genotypes that were contracted be-
fore pregnancy. This seems to confirm that infections, even at a 
submicroscopic level (and then untreated, as most probably not 
accompanied by symptoms), that have occurred before preg-
nancy may persist until (at least) the early stage of pregnancy 
[36], and then be a source of infection during the first trimester.
Additionally, a more thorough analysis showed (1) an inter-
action between those 2 factors (young age and P. falciparum in-
fection status before pregnancy); and (2) a different impact of 
the interaction itself, depending on the trimester of pregnancy. 
Overall, the effects of these factors and their interactions were 
found to be highest in the first trimester, and then to gradu-
ally decrease in the second and third trimesters. Specifically, the 
youngest women with submicroscopic infections before preg-
nancy remained at significantly higher risks of P.  falciparum 
infection (both submicroscopic and microscopic) during all 3 
trimesters, compared to the oldest women with no infection be-
fore pregnancy.
Whereas the importance of P.  falciparum infections (sub-
microscopic and microscopic) during pregnancy was already 
known [15, 21–23, 31], we found that the first trimester was a 
period of a higher prevalence of P.  falciparum infections than 
the rest of pregnancy. Due to the critical importance of P. falcip-
arum infections on early pregnancy [3, 16–18, 37] aggravated 
by the suboptimal protection of pregnant women during this 
period, this result highlights the excess risks faced by pregnant 
women and, therefore, the necessity of improved protection in 
this period.
As expected, we found a significant impact of the number 
of IPTp doses on the risk of having a P.  falciparum infection. 
Figure 5. Predicted probabilities from the ordinal logistic mixed model of the occurrences of submicroscopic Plasmodium falciparum infections per trimester, according to 
maternal age and presence of submicroscopic P. falciparum infection before conception (Retard de Croissance Intra-uterin et Paludisme [RECIPAL] 2014–2017, Benin). P values 
correspond to the t-test comparisons. *Indicates a t-test comparison between the predicted probabilities of having a submicroscopic P. falciparum infection at the first tri-
mester of pregnancy for the youngest women (P value = .1059). **Indicates a t-test comparison between the predicted probabilities of having a submicroscopic P. falciparum 
infection at the second trimester of pregnancy for the youngest women (P value = .5212). ***Indicates a t-test comparison between the predicted probabilities of having a 
submicroscopic P. falciparum infection at the third trimester of pregnancy for the youngest women (P value = .3554).
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The proportions of women with microscopic and submicro-
scopic infections decreased after the first trimester, and the 
minimum was reached in the third trimester. Nevertheless, we 
observed a consistently higher proportion of submicroscopic, 
compared to microscopic, P. falciparum infections, and the pro-
portion of women with a submicroscopic infection remained 
non-negligible throughout pregnancy. In this study, more than 
three-quarters of the women received at least 2 doses of IPTp 
(only 14% had 3 doses), which is higher than the coverage 
reported in Benin [38] and Africa [11], probably due to the 
monthly follow-up.
We also found that ethnicity was associated with a woman’s 
P. falciparum infection status. This could be related to a higher 
exposure to Anopheles by the Toffin, who are located in the lake 
area that is more favorable for transmission of the parasite. 
A woman with a submicroscopic infection at a given trimester 
(first or second) was also significantly more susceptible to in-
fection (submicroscopic/microscopic infection) in the next tri-
mester. This suggests that infections frequently persist during 
pregnancy.
Overall, the results highlight the particular role of submicro-
scopic infections in the dynamics and persistence of P.  falcip-
arum infections during pregnancy.
Our study has some limitations. First, the relatively high 
number of those lost to follow-up during pregnancy (mainly 
because of miscarriages, migrations, and withdrawal of con-
sent due to some refusals of blood and/or placental sampling 
[39]).This could lead to a selection bias. However, a comparison 
of those lost to follow-up and our analysis sample showed no 
significant differences. Additionally, the proportion of primi-
gravidae was low, compared to the proportions in other African 
malaria studies (8.79% vs the 15–25% usually mentioned) [21, 
30, 31]. This could be explained by the PlacMalVac vaccine-
related study, which was conducted simultaneously in the same 
area and included exclusively primigravidae [25]. This under-
representation of primigravidae may have led to a lack of power 
and may explain why the primigravid group did not show sig-
nificant differences with multigravidae, but is unlikely to have 
impacted our results to a large degree.
In conclusion, the RECIPAL study allowed us to study 
the complete dynamics of submicroscopic (as well as micro-
scopic) infections throughout pregnancy, with a particular 
focus on the first trimester. It also made it possible to eval-
uate various factors contributing to these dynamics, and their 
complex interactions. We demonstrated for the first time the 
existence of a large reservoir of submicroscopic infections in 
the first trimester, starting from the very beginning of preg-
nancy. This is of public health importance, since infections 
in early pregnancy are known to be associated with serious 
pregnancy outcomes. In addition, our results seem to confirm 
Figure 6. Predicted probabilities from the ordinal logistic mixed model of the occurrence of microscopic Plasmodium falciparum infections per trimester, according to ma-
ternal age and presence of submicroscopic P. falciparum infection before conception (Retard de Croissance Intra-uterin et Paludisme [RECIPAL] 2014–2017, Benin). P values 
correspond to the t-test comparisons. *Indicates a t-test comparison between the predicted probabilities of having a microscopic P. falciparum infection at the first trimester 
of pregnancy for the youngest women (P value < .0001). **Indicates a t-test comparison between the predicted probabilities of having a microscopic P. falciparum infection 
at the second trimester of pregnancy for the youngest women (P value = .0810). ***Indicates a t-test comparison between the predicted probabilities of having a microscopic 
P. falciparum infection at the third trimester of pregnancy for the youngest women (P value = .5404).
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the link between submicroscopic infections before concep-
tion and infections occurring both in early pregnancy and 
throughout pregnancy. Finally, we found that the youngest 
women with submicroscopic infections before pregnancy 
were a particularly high-risk group for infection not only in 
the first trimester, but also in the rest of pregnancy. Hence, 
focusing on research concerning preconception prevention 
strategies is paramount, including the development of a vac-
cine for nulligravidae [40], to protect women/fetuses against 
the damaging consequences of MiP.
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